Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry

Sarah A. Schwartz, Robert J. Weil, Reid C. Thompson, Yu Shyr, Jason H. Moore, Steven A. Toms, Mahlon Johnson, Richard M. Caprioli

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Clinical diagnosis and treatment decisions for a subset of primary human brain tumors, gliomas, are based almost exclusively on tissue histology. Approaches for glioma diagnosis can be highly subjective due to the heterogeneity and infiltrative nature of these tumors and depend on the skill of the neuropathologist. There is therefore a critical need to develop more precise, nonsubjective, and systematic methods to classify human gliomas. To this end, mass spectrometric analysis has been applied to these tumors to determine glioma-specific protein patterns. Protein profiles have been obtained from human gliomas of various grades through direct analysis of tissue samples using matrix-assisted laser desorption ionization mass spectrometry (MS). Statistical algorithms applied to the MS profiles from tissue sections identified protein patterns that correlated with tumor histology and patient survival. Using a data set of 108 glioma patients, two patient populations, a short-term and a long-term survival group, were identified based on the tissue protein profiles. In addition, a subset of 57 patients diagnosed with high-grade, grade IV, malignant gliomas were analyzed and a novel classification scheme that segregated short-term and long-term survival patients based on the proteomic profiles was developed. The protein patterns described served as an independent indicator of patient survival. These results show that this new molecular approach to monitoring gliomas can provide clinically relevant information on tumor malignancy and is suitable for high-throughput clinical screening.

Original languageEnglish (US)
Pages (from-to)7674-7681
Number of pages8
JournalCancer Research
Volume65
Issue number17
DOIs
StatePublished - Sep 1 2005

Fingerprint

Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Brain Neoplasms
Glioma
Proteomics
Survival
Neoplasms
Proteins
Histology
Mass Spectrometry
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Schwartz, S. A., Weil, R. J., Thompson, R. C., Shyr, Y., Moore, J. H., Toms, S. A., ... Caprioli, R. M. (2005). Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Research, 65(17), 7674-7681. https://doi.org/10.1158/0008-5472.CAN-04-3016

Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. / Schwartz, Sarah A.; Weil, Robert J.; Thompson, Reid C.; Shyr, Yu; Moore, Jason H.; Toms, Steven A.; Johnson, Mahlon; Caprioli, Richard M.

In: Cancer Research, Vol. 65, No. 17, 01.09.2005, p. 7674-7681.

Research output: Contribution to journalArticle

Schwartz, Sarah A. ; Weil, Robert J. ; Thompson, Reid C. ; Shyr, Yu ; Moore, Jason H. ; Toms, Steven A. ; Johnson, Mahlon ; Caprioli, Richard M. / Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. In: Cancer Research. 2005 ; Vol. 65, No. 17. pp. 7674-7681.
@article{887399d2fcc349c5bb324c7d6e0b8799,
title = "Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry",
abstract = "Clinical diagnosis and treatment decisions for a subset of primary human brain tumors, gliomas, are based almost exclusively on tissue histology. Approaches for glioma diagnosis can be highly subjective due to the heterogeneity and infiltrative nature of these tumors and depend on the skill of the neuropathologist. There is therefore a critical need to develop more precise, nonsubjective, and systematic methods to classify human gliomas. To this end, mass spectrometric analysis has been applied to these tumors to determine glioma-specific protein patterns. Protein profiles have been obtained from human gliomas of various grades through direct analysis of tissue samples using matrix-assisted laser desorption ionization mass spectrometry (MS). Statistical algorithms applied to the MS profiles from tissue sections identified protein patterns that correlated with tumor histology and patient survival. Using a data set of 108 glioma patients, two patient populations, a short-term and a long-term survival group, were identified based on the tissue protein profiles. In addition, a subset of 57 patients diagnosed with high-grade, grade IV, malignant gliomas were analyzed and a novel classification scheme that segregated short-term and long-term survival patients based on the proteomic profiles was developed. The protein patterns described served as an independent indicator of patient survival. These results show that this new molecular approach to monitoring gliomas can provide clinically relevant information on tumor malignancy and is suitable for high-throughput clinical screening.",
author = "Schwartz, {Sarah A.} and Weil, {Robert J.} and Thompson, {Reid C.} and Yu Shyr and Moore, {Jason H.} and Toms, {Steven A.} and Mahlon Johnson and Caprioli, {Richard M.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-04-3016",
language = "English (US)",
volume = "65",
pages = "7674--7681",
journal = "Cancer Research",
issn = "0008-5472",
number = "17",

}

TY - JOUR

T1 - Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry

AU - Schwartz, Sarah A.

AU - Weil, Robert J.

AU - Thompson, Reid C.

AU - Shyr, Yu

AU - Moore, Jason H.

AU - Toms, Steven A.

AU - Johnson, Mahlon

AU - Caprioli, Richard M.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Clinical diagnosis and treatment decisions for a subset of primary human brain tumors, gliomas, are based almost exclusively on tissue histology. Approaches for glioma diagnosis can be highly subjective due to the heterogeneity and infiltrative nature of these tumors and depend on the skill of the neuropathologist. There is therefore a critical need to develop more precise, nonsubjective, and systematic methods to classify human gliomas. To this end, mass spectrometric analysis has been applied to these tumors to determine glioma-specific protein patterns. Protein profiles have been obtained from human gliomas of various grades through direct analysis of tissue samples using matrix-assisted laser desorption ionization mass spectrometry (MS). Statistical algorithms applied to the MS profiles from tissue sections identified protein patterns that correlated with tumor histology and patient survival. Using a data set of 108 glioma patients, two patient populations, a short-term and a long-term survival group, were identified based on the tissue protein profiles. In addition, a subset of 57 patients diagnosed with high-grade, grade IV, malignant gliomas were analyzed and a novel classification scheme that segregated short-term and long-term survival patients based on the proteomic profiles was developed. The protein patterns described served as an independent indicator of patient survival. These results show that this new molecular approach to monitoring gliomas can provide clinically relevant information on tumor malignancy and is suitable for high-throughput clinical screening.

AB - Clinical diagnosis and treatment decisions for a subset of primary human brain tumors, gliomas, are based almost exclusively on tissue histology. Approaches for glioma diagnosis can be highly subjective due to the heterogeneity and infiltrative nature of these tumors and depend on the skill of the neuropathologist. There is therefore a critical need to develop more precise, nonsubjective, and systematic methods to classify human gliomas. To this end, mass spectrometric analysis has been applied to these tumors to determine glioma-specific protein patterns. Protein profiles have been obtained from human gliomas of various grades through direct analysis of tissue samples using matrix-assisted laser desorption ionization mass spectrometry (MS). Statistical algorithms applied to the MS profiles from tissue sections identified protein patterns that correlated with tumor histology and patient survival. Using a data set of 108 glioma patients, two patient populations, a short-term and a long-term survival group, were identified based on the tissue protein profiles. In addition, a subset of 57 patients diagnosed with high-grade, grade IV, malignant gliomas were analyzed and a novel classification scheme that segregated short-term and long-term survival patients based on the proteomic profiles was developed. The protein patterns described served as an independent indicator of patient survival. These results show that this new molecular approach to monitoring gliomas can provide clinically relevant information on tumor malignancy and is suitable for high-throughput clinical screening.

UR - http://www.scopus.com/inward/record.url?scp=24744457360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744457360&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3016

DO - 10.1158/0008-5472.CAN-04-3016

M3 - Article

C2 - 16140934

AN - SCOPUS:24744457360

VL - 65

SP - 7674

EP - 7681

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 17

ER -